Patients with Complex IBD at Increased Risk of Renal Cell Carcinoma, but with Better Survival Outcomes

Patients with Complex IBD at Increased Risk of Renal Cell Carcinoma, but with Better Survival Outcomes
In a new study entitled “Better survival of renal cell carcinoma in patients with inflammatory bowel disease”, researchers investigated whether the commonly used immunosuppressive and anti-TNFα therapies in inflammatory bowel disease (IBD) affect a patients’ risk to develop cancer, especially renal cell carcinoma (RCC). The study was published in the journal Oncotarget. IBD comprises a group of

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *